Nodenza Venture Partners
228 Park Ave S PMB 67135, New York, NY, 10003-1502, United States
Overview
Nodenza Venture Partners invests globally in early-stage and pre-commercial companies that have the greatest potential to positively impact patients lives.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Venture Capital
Investment portfolio
- Insight Surgery
Led · Series A · May 2025
Insight Surgery offers the EmbedMed platform to process patient scans, enable advanced digital surgical planning and deliver either virtual plans or bespoke 3D-printed surgical guides—typically within 10 working days. The company’s guides are manufactured at an ISO 13485‑certified, FDA‑registered facility in Houston at the Texas Medical Center and use FDA‑cleared materials such as LaserForm Ti and DuraForm ProX PA. Clinical studies cited in the article report 3D‑printed guides can reduce operative time by an average of 23 minutes per case, improving outcomes and lowering costs and readmissions. Since launching in the US in 2023, Insight has formed partnerships with Ricoh USA and several leading hospitals, including Hospital for Special Surgery, University Hospitals of Chicago, University of Florida Health, and UAB. The company plans to deepen US presence, open two new hospital‑site manufacturing facilities on the East and West Coasts, double its US headcount, broaden applications into maxillofacial and oncology procedures, and explore integrating AI and machine learning into its planning platform.
Team
No current team members are available.